McKinstry Nancy
- SEC CIK
- 0001294731
No open-market purchases or sales filed in the past year.
Current role at each company
- ACN Accenture plcDirectoras of Aug 17, 2026
- MDLZ Mondelez International, Inc.Directoras of May 21, 2026
- ABT Abbott LaboratoriesDirectoras of Apr 28, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists McKinstry Nancy as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ABT Abbott Laboratories
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2022 (view filing) | Feb 24 | 1 day | McKinstry NancyDirector | SSaleCommon shares without par value | −1.61K | $116.43 | −$187.9K | −4.8%31.8K after |